As of May 9 09:40 A.M., EUGENE slightly edged down 0.83 percent to 6,010 won. It had declined 17.22 percent through the past month. It is a leading company in the sector of basic construction materials in Korea. 

Compared with its close competitors within the same industry, KOSDAQ, even though the monthly volatility of EUGENE was the lowest, the earnings rate over one month was also the lowest with a decline of stock price.

Comparing industry to the market, the KOSDAQ industry including EUGENE records higher volatility but lower earning rate than Non-metal. Even though the earning rate of the industry is negative, the industry was more satisfactory than the market.

Institutions & Foreigners sell, Individuals buy

While Institutions have been buying EUGENE during the past 2 trading day, Foreigners have been selling during the past 14 trading day.

As a shareholding sum by the investor group for the past 4 weeks, Foreigners have sold 1,371,524 shares with the maintenance of a selling position and Institutions have sold 128,078 shares with a selling trend.

However, during the same period, Individuals have bought 1,488,625 shares with an increasing position.

Regarding the statistics for the past month on trade volume as the total outstanding shares, the daily turnover rate of EUGENE was 0.65 percent. And the daily volatility, the average range of rise and fall, during the same period is 2.4 percent.

As per the inquiry for shareholding by the investor group, the major investor group is Individuals with 66.21 percent from total outstanding shares. Foreigners and Institutions each hold 21.71 percent and 10.75 percent.

And as recent 5-day shareholding change by the investor group, Individuals is the major investor group with 61.7 percent. Foreigners hold 20.88 percent and Institutions hold 15.37 percent.

(Editorial Note) This article is provided by ThinkPool, a Korean artificial intelligence developer. Its AI algorithm automatically produced this article, which is edited with Google Grammarly. If there are any issues or if readers have any comments, please contact or 82-2-6956-6698.

Artificial intelligence algorithm of ThinkPool automatically produced this article, which is edited with Google Grammarly.